Brain cortical alterations in COVID-19 patients with neurological symptoms.

Sanabria-Diaz, Gretel; Etter, Manina Maja; Melie-Garcia, Lester; Lieb, Johanna M; Psychogios, Marios-Nikos; Hutter, Gregor; Granziera, Cristina

Sanabria-Diaz, Gretel; Etter, Manina Maja; Melie-Garcia, Lester; Lieb, Johanna M; Psychogios, Marios-Nikos; Hutter, Gregor; Granziera, Cristina.

Afiliación

Sanabria-Diaz G; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Etter MM; Department of Neurology, University Hospital Basel, Basel, Switzerland.
Melie-Garcia L; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Lieb JM; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Psychogios MN; Division of Neurosurgery, University Hospital Basel, Basel, Switzerland.
Hutter G; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Granziera C; Department of Neurology, University Hospital Basel, Basel, Switzerland.

Front Neurosci ; 16: 992165, 2022.

Article en En | MEDLINE | ID: mdl-36340780

Palabras clave

COVID-19; SARS-CoV-2; cortical thickness; gray matter volume (GMV); neurological symptoms; surface area

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Neurosci Año: 2022 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google